Search

everythinglearnresearchcommunity

for

Search:↓

A patient with Cronkhite-Canada Syndrome developed colon cancer that spread to the liver, showing the need for regular cancer checks in such patients.

Hair loss in African American women, caused by hair care, genetics, and environment, needs more research for better treatment.

CCCA and lichen planopilaris have similar histological features, making them hard to distinguish.

About 8% of people with systemic lupus erythematosus have chronic scarring alopecia, with certain symptoms and positive antibodies increasing the risk, while immunosuppressants may lower it.

A 60-year-old man with Cronkhite-Canada syndrome improved with treatment, but the condition has a high mortality rate and a risk of colorectal cancer.

Sertoliform endometrioid carcinoma of the ovary, though rare, has a good prognosis when treated early.

CCCA may involve the PD1/PDL1 pathway and increased caspase 3, leading to permanent hair loss.

Men with CCCA often face delayed diagnosis and severe hair loss, highlighting the need for earlier recognition and treatment.

CCCA may be a fibroproliferative disorder, and anti-fibrotic therapies could help.

CCCA can appear as patchy hair loss in younger men, not just the usual pattern.

Basal cell carcinoma cases are rising globally.

Lower SMAD2/3 activation predicts more severe skin cancer.

The tumor suppressor BRCA2 helps in cell division by bringing key proteins to the area where cells split.

Early diagnosis and treatment with corticosteroids can improve outcomes in Cronkhite–Canada syndrome.

Patients with central centrifugal cicatricial alopecia may have a higher risk of breast and colorectal cancer.

Traditional Chinese medicine may help relieve symptoms of Cronkhite-Canada syndrome.

The document concludes that central centrifugal cicatricial alopecia (CCCA) should be considered in African American men with vertex hair loss and scalp symptoms, and that prompt diagnosis and treatment can slow disease progression.

AP-1 and TGFß work together to drive resistance in basal cell carcinoma, suggesting new treatment options.

Dr. Connelly agrees that linear basal cell carcinomas might be more aggressive but highlights the study's lack of clear criteria to identify them.

There is no standard treatment for CCCA, and practices vary widely.

Blocking Hedgehog signaling offers new treatment options for advanced basal cell carcinoma.

The conclusion is that hair loss from CCCA may be genetic and not solely caused by hair grooming practices.

A mouse model for studying scleroderma in chronic graft-versus-host disease was successfully created.

Photodynamic therapy successfully treated skin cancer in a 53-year-old woman.

CCCA may be caused by both hair traction and an immune response.

LC-OCT can help diagnose different types of scarring alopecia.

Researchers found a white halo around hair in most patients with a specific type of hair loss, which helps in early diagnosis and treatment.

Hair loss in black women needs more research, early intervention, and community education.

Mutations in the PADI3 gene may cause central centrifugal cicatricial alopecia in women of African ancestry.